Diagnosis & Treatment

New mobile app helps patients with PTSD through prolonged exposure

August 21, 2012    
news

A mobile app will help patients suffering from PTSD by assisting them with prolonged exposure therapy in between their sessions.

Who’s in Charge?

August 21, 2012    
blog

Ron Manderscheid asks, "Are behavioral health providers prepared to cope with the expected new workload under the ACA?"

Netsmart acquires Behavioral Pathway Systems

August 21, 2012    
news

BPS' benchmarking capabilities will be integrated into Netsmart product offerings

Trans-cranial magnetic stimulation (TMS) therapy demonstrated

August 13, 2012     Dennis Grantham, Editor-in-Chief
blog

FDA approves OraSure Technologies' at-home HIV test

July 5, 2012    
news

Oral swab test offers HIV test results, at home, in as little as 20 minutes.

ValueOptions, American Well envision national telebehavioral health network

June 27, 2012    
news

Now under development, telehealth network will take advantage of growing number of states that reimburse for telehealth services

New TMS data released at 2012 APA annual meeting

May 15, 2012     News release
news

Data released at the annual meeting of the American Psychiatric Association show that patients with unipolar, non-psychotic MDD who received transcranial magnetic stimulation (TMS) therapy achieved significant improvements.

Clinical trial completed on new PTSD treatment technology

May 14, 2012     News release
news

At Ease USA, a Nebraska organization dedicated to providing confidential post-traumatic stress disorder (PTSD) care for military families, has launched a clinical trial of a promising new therapeutic intervention at Creighton University.

Transforming our understanding of the causes and treatment of mental disorders

April 16, 2012     Dennis Grantham, Editor-in-Chief
article

NIMH Director Insel describes a new understanding of mental illness as "complex circuit disorders of the brain"

Ridge Diagnostics enters licensing agreement for depression blood test

April 9, 2012    
news

Ridge Diagnostics has announced it has entered into an exclusive agreement with Ameritox Ltd., a provider of medication monitoring, for the license rights to its proprietary developmental blood test MDDScore, a multiple biomarker analysis for Major Depressive Disorder (MDD) for primary care and pain physicians.

Comparing antidepressants? There’s an app for that

March 28, 2012     Nick Zubko, Associate Editor
blog

There’s an “app” for everything these days. Now there's one that's supposed to “recommend antidepressant therapies specific to different patient characteristics.” And you can get it for less than $5.

PreviousPage
of 5Next